anti-CCL20 antibodies (Hadassah University Hospital/Hadasit Medical Research Services and Development)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Nameanti-CCL20 antibodies (Hadassah University Hospital/Hadasit Medical Research Services and Development)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionC-C motif chemokine 20 inhibitors
TargetsC-C motif chemokine 20
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAlbania
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesHadassah University Hospital
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesHadassah University Hospital
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A